Cargando…
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
Resistance of progressive cancers against chemotherapy is a serious clinical problem. In this context, human epidermal growth factor receptor 3 (HER3) can play important roles in drug resistance to HER1- and HER2- targeted therapies. Since clinical testing of anti-HER3 monoclonal antibodies (mAbs) s...
Autores principales: | Okita, Kouki, Okazaki, Shogo, Uejima, Shinya, Yamada, Erina, Kaminaka, Hiroki, Kondo, Misa, Ueda, Shiho, Tokiwa, Ryo, Iwata, Nami, Yamasaki, Akitaka, Hayashi, Natsumi, Ogura, Dai, Hirotani, Kenji, Yoshioka, Toshiaki, Inoue, Masahiro, Masuko, Kazue, Masuko, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967776/ https://www.ncbi.nlm.nih.gov/pubmed/32002122 http://dx.doi.org/10.18632/oncotarget.27414 |
Ejemplares similares
-
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target
por: Hayashi, Natsumi, et al.
Publicado: (2021) -
Dual‐targeting therapy against HER3/MET in human colorectal cancers
por: Yamasaki, Akitaka, et al.
Publicado: (2023) -
Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
por: Hara, Yuta, et al.
Publicado: (2019) -
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene
por: Okita, Kouki, et al.
Publicado: (2020) -
Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
por: Ueda, Shiho, et al.
Publicado: (2019)